U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07113470) titled 'Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache' on July 29.
Brief Summary: This is a limited open-label study being performed at two centers in the Netherlands. All participants will receive the same treatment, and both the patients and doctors will know what that treatment is. The goal is to see how safe and effective the PRIMUS system is for preventing Chronic Cluster Headaches (CCH) in people who haven't responded well to the drug verapamil. The study will also look at the patients' experience using the system.
Study Start Date: Dec. 01, 2025
Study Type: I...